provider_review · verified 2026-08-07

Sprout Health review

An open FDA warning letter sits on this company's record

The FDA issued a warning letter to Sprout Health Partners LLC dba Sprout Health in September 2025; we still link to the company, we are still paid when a reader starts care through that link, and that is why the letter is the first thing on this page rather than a footnote at the bottom of it.

How this site makes money

Plain version: a handful of the outbound links here are affiliate or referral links. Follow one, start a treatment or buy a product, and we may earn a commission — your price stays exactly the same. That money pays for the research, and what we write about any product — and the price you pay — are the same either way. Want the specifics? Read the full disclosure.

FDA warning letter. The FDA issued a warning letter to Sprout Health Partners LLC dba Sprout Health in September 2025. You can look it up on the FDA’s warning-letter index.

visit Sprout Health

at_a_glance

price: Four treatment tiles on the public landing page: "Compounded Semaglutide — Starting at $149", "Compounded Tirzepatide — Starting at $199", "Wegovy® — Starting at $1,579" and "Zepbound® — Starting at $1,249". A separate footer bar reads "Personalized GLP-1 care from $99 first month · cancel anytime".
what you pay: $149/month is the lowest figure attached to an actual product (compounded semaglutide), with tirzepatide at $199. All four are "starting at" prices set at intake, and Sprout's own FAQ says a clinician reviews each refill and "decide[s] whether to adjust your dose" — the mechanism by which a starting price stops being the price.
pharmacy: Named, but not where a buyer is looking. The landing page says only that medication ships "from a US pharmacy" to "one of our partner pharmacies", under a trust strip claiming "Sourced from licensed U.S. pharmacies". Section 29 of the Terms ("External Services Contacts") and the same block in the HIPAA notice do name them: MDI (MD Integrations) as the clinician network, Foothills Pharmacy and Promise Pharmacy, each with a contact address. Neither pharmacy is classified — "503A" and "503B" appear on none of the 56 pages in Sprout's sitemap. The company is Sprout Health Partners LLC, listed at 1042 El Camino Real, Encinitas, CA 92024, and the site claims LegitScript certification. That entity name matters here: it is the one on the FDA warning letter.
states: No state list is published. Eligibility is settled by the pre-qualification quiz, so a reader finds out whether they can be served only after answering it.
on our index: Not ranked. Not ranked on /best-nad, and never will be: Sprout Health sells no NAD+ product of any kind. It is a compounded-GLP-1 weight-loss telehealth, surfaced only inside the clearly labeled adjacent module on our NAD+-for-weight-loss page, where the point being made is that NAD+ is not a weight-loss drug and GLP-1 medications are. This page exists because we link to the company and are paid when readers start care through that link, and because it is operating under an FDA warning letter that a reader deserves to know about before clicking.

verdict

The short version

Start with the fact that decides whether you read any further: in September 2025 the FDA issued a warning letter to Sprout Health Partners LLC dba Sprout Health, the entity named in the copyright line at the bottom of the page our link sends you to. The letter is public, it concerns the unlawful sale of unapproved and misbranded drugs to US consumers over the internet, and it is on the record. We are paid a commission when someone starts care through our link, we have not removed that link, and we are telling you about the letter in the same breath — you can weigh both. On the commercial merits, Sprout is a legible operator: four treatment tiles with prices on them, compounded semaglutide from $149 and compounded tirzepatide from $199 alongside genuine brand-name Wegovy at $1,579 and Zepbound at $1,249, a two-minute quiz, and its own compounded-drug disclosure printed in the footer. Two things to hold against that. You pay before the detailed medical questionnaire is completed, refunded if a clinician declines you. And a footer bar advertises "from $99 first month", a figure that appears on no treatment tile.

evidence

What the evidence for this route shows

The route question this site normally asks does not apply here, and saying so plainly is more useful than forcing it: Sprout Health sells no NAD+ in any form, so there is no NAD+ delivery route to assess. What it sells are GLP-1 receptor agonists, and that class does have what NAD+ therapy does not — large randomized controlled trials with hard weight and cardiometabolic endpoints. The important qualifier is that those trials tested the FDA-approved branded products, not the compounded semaglutide and tirzepatide that are Sprout's two cheapest tiles. Sprout states the distinction itself in its footer: compounded GLP-1 and GIP/GLP-1 medications "are not approved by the FDA and have not been evaluated for safety, effectiveness, or quality by the FDA." Read alongside our own evidence page, the summary is that GLP-1 drugs work for weight loss and NAD+ does not, and that a compounded copy inherits the molecule but not the trial data.

pricing

What it actually costs

advertised: Four treatment tiles on the public landing page: "Compounded Semaglutide — Starting at $149", "Compounded Tirzepatide — Starting at $199", "Wegovy® — Starting at $1,579" and "Zepbound® — Starting at $1,249". A separate footer bar reads "Personalized GLP-1 care from $99 first month · cancel anytime".
you pay: $149/month is the lowest figure attached to an actual product (compounded semaglutide), with tirzepatide at $199. All four are "starting at" prices set at intake, and Sprout's own FAQ says a clinician reviews each refill and "decide[s] whether to adjust your dose" — the mechanism by which a starting price stops being the price.
the catch: Two, and they pull in opposite directions. The "$99 first month" in the footer bar is attached to no treatment tile and is $50 below the cheapest product price on the same page, so it is an entry teaser rather than a rate. And every tile says "Starting at", while the refill FAQ describes a monthly clinician check-in that can change your dose — so what the tile quotes is a floor for a plan whose contents are adjusted month to month.

Other money you will meet

Payment is taken before the detailed medical questionnaire is reviewed; the order is canceled and refunded if a clinician declines you
Shipping is included, quoted at 3–7 business days after a prescription is issued
Cash-pay — the site describes no insurance path, so none of this is reimbursable
Plans renew monthly on the same date; pausing or canceling is self-service in the account

source :: read at go.joinsprouthealth.com on 2026-08-07, in a browser that runs JavaScript.

fit

Who this is and is not for

Buy it if

You have read the FDA warning letter, or at least know it exists, and have decided that is a risk you are prepared to carry
You want a compounded and a brand-name path priced side by side rather than a compounded-only funnel
You are already on a GLP-1 and want to transfer a dose without restarting a titration
You want prices visible before a quiz — four tiles carry figures on the public page

Look elsewhere if

You want a provider with no open FDA action attached to it — that alone is a reason to look elsewhere, and there are others in this category
You want to pay only after a clinician has reviewed your full medical questionnaire
You want the dispensing pharmacy named where you are buying, not in section 29 of the Terms
You want NAD+ — Sprout sells none, and nothing on this site ranks it as an NAD+ provider

included

What is inside the price

consult: Yes, and in an unusual order. A free two-minute pre-qualification quiz comes first, then you purchase, and only then — in Sprout's own words — "you'll fill out a more detailed medical questionnaire that goes to your assigned licensed clinician." Nothing ships until that clinician issues a prescription, and an order is canceled and refunded if they decide treatment is not appropriate.
labs: Not mentioned anywhere on the landing page or its FAQ. No bloodwork step is described in either direction, which is a silence rather than a stated policy.
follow-ups: Included and described concretely: the plan renews monthly, and "before each refill, you'll complete a short check-in so your clinician can review your progress and decide whether to adjust your dose."
human support: Clinician messaging inside the Sprout account, plus a care team reachable by phone Monday to Friday, 9:00am–5:30pm Mountain, and by email.
supplies: Not itemized on the pages we read.
shipping: Included. Orders "typically ship within 3-7 business days" once a prescription is issued, in discreet refrigerated packaging, with tracking emailed and visible in the account.

the_knock

What they would rather you skipped

The FDA issued a warning letter to Sprout Health Partners LLC dba Sprout Health in September 2025, and it is on the agency's public record under that name: search the FDA warning-letter database for "Sprout Health Partners" and that letter is the only record it returns. We are not going to characterize the agency's case here — the letter is published and states it better than any summary of ours would — but its existence and its date are not optional information for someone about to hand this company a payment and a medical history, so they appear on this page, in the module that links to the company, and in the list above. The second knock is structural and separate: Sprout takes your money before the detailed medical questionnaire reaches a clinician. The quiz that precedes the payment is a pre-qualification screen, not the evaluation; the evaluation happens after checkout, and a decline results in a cancellation and a refund. That is a defensible telehealth pattern and several providers on this site use it, but combined with an open FDA action about unapproved drugs sold over the internet, the sequencing deserves to be stated rather than glossed. We earn a commission on this link. That is exactly why both paragraphs are here.

And the rest

An FDA warning letter issued in September 2025 to Sprout Health Partners LLC dba Sprout Health, the entity operating the site our link points to, is on the public record
You pay before the detailed medical questionnaire is reviewed, with a refund only if a clinician declines you
The "from $99 first month" footer bar is attached to no treatment tile and sits $50 under the cheapest product price on the same page
The two dispensing pharmacies are named only in the Terms and the HIPAA notice, and neither is classified — no 503A/503B designation is published anywhere on the site
No state-availability list — eligibility is discovered by taking the quiz
This site earns a commission when a reader starts care through this link, and the link has been kept

tools

Work out your own number

NAD+ therapy cost calculator

visit Sprout Health

Every figure on this page was read on Sprout Health’s own site on 2026-08-07 in a browser that runs JavaScript, and prices change without notice. Read every provider review.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.